Takeda Pharmaceutical (TAK) Debt Ratio (2018 - 2026)

Takeda Pharmaceutical's Debt Ratio history runs 9 years deep, the most recent figure standing at 0.32 for Q1 2026.

• In Q1 2026, Debt Ratio rose 0.85% year-over-year to 0.32; the TTM figure through Mar 2026 stood at 0.32 (up 0.85% YoY), while the FY2026 annual figure was 0.32, up 0.85% from the prior year.
• Debt Ratio was 0.32 for Q1 2026 at Takeda Pharmaceutical, up from 0.31 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.35 in Q4 2024 to a low of 0.05 in Q1 2022.
• Historically, Debt Ratio has averaged 0.3 across 5 years, with a median of 0.33 in 2022.
• The sharpest annual moves came in 2023 and 2024: Debt Ratio surged 522.17% in 2023, then tumbled 82.48% in 2024.
• A 5-year view of Debt Ratio shows it stood at 0.33 in 2022, then advanced by 3.92% to 0.34 in 2023, then climbed by 3.1% to 0.35 in 2024, then decreased by 10.42% to 0.31 in 2025, then increased by 1.82% to 0.32 in 2026.
• The last three Debt Ratio figures came in at 0.32 (Q1 2026), 0.31 (Q4 2025), and 0.34 (Q3 2025), per Business Quant data.